Dunhui Li

Dunhui Li serves as an Associate Research Scientist in the Department of Neurology at Yale School of Medicine. Dr. Li maintains a dual appointment in Neurology and is affiliated with the Adams Center for Parkinson's Disease Research, focusing on neurodegenerative disorders with particular emphasis on Parkinson's disease research.

Dr. Li's research program spans multiple critical areas in neuroscience and molecular medicine:

• Parkinson's Disease Mechanisms and Therapeutics
• Neurodegenerative Disorders
• Molecular Targeting Strategies
• Antisense Oligonucleotide Therapies
• Gene Therapy Approaches
• Neurological Disease Biomarkers

Dr. Li's publication record demonstrates a strong focus on molecular approaches to neurodegenerative diseases, with particular expertise in antisense oligonucleotides and gene therapy for Parkinson's disease. Recent work explores personalized approaches to suppress or replenish SNCA (alpha-synuclein), controversies in neuronal regeneration strategies, and applications of molecular therapeutics for rare neurological conditions. The research spans from basic molecular mechanisms to potential clinical applications, often bridging neurology with cutting-edge molecular biology techniques.

With 28 publications and 583 citations, Dr. Li has established a productive research career contributing significantly to the understanding and treatment of neurodegenerative disorders. The work frequently appears in high-impact journals including Npj Parkinson's Disease, Translational Neurodegeneration, and Frontiers in Neuroscience.

Dr. Li maintains active collaborations with researchers including Mastaglia F, Wilton S, Yau W, Chen S, and other leading experts in neurology and molecular therapeutics. The research is conducted within the Department of Neurology at Yale School of Medicine, with specific affiliation to the Adams Center for Parkinson's Disease Research, which provides a dedicated environment for Parkinson's disease investigation.